Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Gadodiamide 0.5 mmol/mL solution for injection |
Has concentration strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely bacitracin 500 unit/1 gram conventional release eye ointment (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Bacitracin 500 unit/g cutaneous ointment |
Has concentration strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely oxygen 0.995 milliliter/1 milliliter conventional release gas for inhalation (clinical drug) |
Has concentration strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Nitrous oxide 0.5 mL/mL and oxygen 0.5 mL/mL gas for inhalation |
Has concentration strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Nitrous oxide 0.5 mL/mL and oxygen 0.5 mL/mL gas for inhalation |
Has concentration strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
2 |
Product containing precisely alosetron 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely warfarin sodium 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely risperidone 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely naloxone hydrochloride 500 microgram and pentazocine hydrochloride 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Varenicline 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Rasagiline 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely estradiol 1 milligram and norethisterone acetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
2 |
Ethinyl estradiol 0.035 mg and norethindrone 0.5 mg oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely dutasteride 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely doxercalciferol 500 nanogram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Ethinyl estradiol 2.5 microgram and norethindrone acetate 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
2 |
Entecavir 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely colchicine 500 microgram and probenecid 500 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely deserpidine 500 microgram and methyclothiazide 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
2 |
Product containing precisely estradiol 500 microgram and norethisterone acetate 100 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Drospirenone 500 microgram and estradiol 1 mg oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
2 |
Benztropine mesylate 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Ethinyl estradiol 50 microgram and norgestrel 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
2 |
Anagrelide hydrochloride 500 microgram oral capsule |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely prazosin (as prazosin hydrochloride) 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely cilazapril 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely trandolapril 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely lormetazepam 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Alprazolam 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Haloperidol 500 microgram oral capsule |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Haloperidol 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Flupentixol 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Pizotyline 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely clonazepam 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
dexamethasone cp à 0,5mg |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Repaglinide 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely etynodiol diacetate 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely tacrolimus 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Colchicine 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely potassium aminobenzoate 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely bumetanide 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely sodium fluoride 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely metolazone 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely thiamazole 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Estradiol 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely lorazepam 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely nabilone 500 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Ropinirole hydrochloride 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely everolimus 500 microgram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely dutasteride 500 microgram and tamsulosin hydrochloride 400 microgram/1 each conventional release oral capsule (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
2 |
Cabergoline 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Pramipexole dihydrochloride 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely fluphenazine hydrochloride 500 microgram and nortriptyline 10 milligram/1 each conventional release oral tablet (clinical drug) |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Alfacalcidol 500 nanogram oral capsule |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Ethinyl estradiol 35 microgram and norethindrone 500 microgram oral tablet |
Has presentation strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely dinoprostone 5 milligram/0.5 milliliter conventional release solution for infusion ampule (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Flupentixol decanoate 50 mg/0.5 mL solution for injection ampule |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely fluphenazine decanoate 50 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely fluphenazine decanoate 12.5 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely choriogonadotropin alfa 250 microgram/0.5 milliliter conventional release solution for injection syringe (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Epoetin alfa 5000 unit/0.5 mL solution for injection syringe |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely epoetin alfa 1000 unit/0.5 milliliter conventional release solution for injection syringe (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely alfacalcidol 1 microgram/0.5 milliliter conventional release solution for injection ampule (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Epoetin alfa 2000 unit/0.5 mL solution for injection syringe |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely dalteparin sodium 12500 unit/0.5 milliliter conventional release solution for injection syringe (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Fondaparinux sodium 2.5 mg/0.5 mL solution for injection syringe |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Peginterferon alfa-2a 180 microgram/0.5 mL solution for injection syringe |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely ganirelix 250 microgram/0.5 milliliter conventional release solution for injection syringe (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Phytonadione 1 mg/0.5 mL solution for injection ampule |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely heparin calcium 12500 unit/0.5 milliliter conventional release solution for injection syringe (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Tinzaparin sodium 10000 unit/0.5 mL solution for injection syringe |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely peginterferon alfa-2a 135 microgram/0.5 milliliter conventional release solution for injection syringe (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely hepatitis B surface antigen 10 microgram/0.5 milliliter conventional release suspension for injection vial (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Gadodiamide 5 mmol/10 mL solution for injection vial |
Has concentration strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Gadodiamide 7.5 mmol/15 mL solution for injection vial |
Has concentration strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Gadodiamide 10 mmol/20 mL solution for injection vial |
Has concentration strength numerator value (attribute) |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 10 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 50 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |
Product containing precisely sodium aurothiomalate 20 milligram/0.5 milliliter conventional release solution for injection ampule (clinical drug) |
Has presentation strength denominator value |
False |
0,5 |
Inferred relationship |
Some |
1 |